You are about to exit for another SJM country or region specific website.
Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions.
The website you have requested also may not be optimized for your specific screen size.
Results 1-10 of 154
Join us as we review the impact of the 2017 comprehensive ambulatory payment classification (C-APC 5200) payment for your hospital and CardioMEMS™ HF System patients.
Join us as we address frequently asked questions and scenarios regarding remote monitoring, and take an educational review of coding, coverage, and reimbursement for remote monitoring of cardiac implantable devices.
Ever since a patient received our revolutionary first heart valve, a product that changed the industry and quickly became the gold standard, we have transformed patients’ lives.
In this program, “Knowing, Not Guessing: New Insights Into Heart Failure Patient Management,” heart failure professionals discuss the link between PA pressure monitoring with the CardioMEMS™ HF System and HF hospitalization reductions.
We are proud of our work to help save and improve lives, including our many decades of valve innovations.
See an in-depth description and demonstration of the Agilis™ NxT steerable introducer.
See the introduction to a series of procedural videos about the AMPLATZER™ Duct Occluder II, designed for the patent ductus arteriosus.
Learn about the components of the AMPLATZER™ Duct Occluder II and AMPLATZER™ delivery systems.
Learn the necessary measurements and evaluations to accurately size the defect and select the correct device size.
See how to prepare the AMPLATZER™ Duct Occluder II for delivery to the patent ductus arteriosus.